{"id":"W2994601580","doi":"10.1186/s13058-019-1240-y","title":"Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer","year":2020,"lang":"en","type":"erratum","venue":"Breast Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Trastuzumab; Neratinib; Medicine; Surgical oncology; Paclitaxel; Oncology; Breast cancer; Internal medicine; Chemotherapy; Neoadjuvant therapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.003487244,0.001365324,0.004107778,0.001194137,0.0007560059,0.0005054286,0.0006175907,0.0009376118,0.003003475],"category_scores_gemma":[0.0007535901,0.0009806511,0.00034285,0.002772175,0.001436564,0.0003390692,0.0003935136,0.006691759,0.00001841436],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.003944185,"about_ca_system_score_gemma":0.01328259,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04243099,"about_ca_topic_score_gemma":0.01685913,"domain_scores_codex":[0.9874354,0.00221798,0.001507686,0.002783653,0.003780679,0.002274629],"domain_scores_gemma":[0.9945562,0.0009151435,0.0003386836,0.0008985236,0.001452722,0.001838657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4716319,0.0009829246,0.00006276053,0.0003751176,0.0005087208,0.0002600561,0.003203537,0.000003205665,0.0008868095,0.000003323306,0.4365527,0.08552892],"study_design_scores_gemma":[0.8313703,0.01776464,0.000846252,0.007252425,0.0003430257,0.001315824,0.002008748,0.00231959,0.0002601495,0.00001004045,0.1350991,0.001409939],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4004245,0.04310744,0.0003479946,0.392056,0.03475608,0.09390112,0.02249602,0.0008398246,0.01207102],"genre_scores_gemma":[0.4733797,0.06242136,0.0004494908,0.006962426,0.01778399,0.04808064,0.00182847,0.001821829,0.3872721],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3850935,"threshold_uncertainty_score":0.9999098,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04353015785997257,"score_gpt":0.4212546769172177,"score_spread":0.3777245190572452,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}